Cefiderocol
Cefiderocol is a siderophore cephalosporin antibiotic used to treat serious bacterial infections caused by susceptible Gram-negative bacteria, including complicated urinary tract infections, pyelonephritis, hospital-acquired bacterial pneumonia and ventilator-associated pneumonia. It works by binding iron and using bacterial iron-transport systems to enter bacterial cells, where it inhibits cell-wall synthesis and causes bacterial death. Cefiderocol is supplied as a powder for reconstitution and administered by intravenous infusion under specialist medical supervision. Common side effects include diarrhoea, nausea, vomiting, constipation, rash and infusion-site reactions. Serious risks include severe allergic reactions, Clostridioides difficile-associated diarrhoea and seizures or other neurological effects, particularly in susceptible patients. Kidney function should be assessed for appropriate dosing, and use should be guided by bacterial culture and susceptibility results when available.
Cefiderocol was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cefiderocol, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Cefiderocol from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Cefiderocol, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
